Additionally, antithrombotic therapy with aspirin or P2Y12 inhibitors, beta‐blockers, ACE inhibitors, or ARBs is recommended for specific clinical profiles, such as those with a history of myocardial infarction (MI), heart failure or hypertension. The gene discussed is P2RY12; the disease is myocardial infarction.